Navigation Links
Upsher-Smith Introduces Nexa™ Select With More Plant-Based DHA Than Any Other Once-Daily Single Gel Capsule Rx Prenatal Vitamin

MAPLE GROVE, Minn., Feb. 7, 2011 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. announces the launch of Nexa™ Select Rx prenatal vitamin, the newest addition to the Nexa™ Prenatal Vitamin Family.  Nexa™ Select contains plant-based DHA (325 mg) and Vitamin D3 (800 IU). Its advanced formulation offers more plant-based DHA than any other single gel capsule Rx prenatal vitamin taken once a day.  Many experts recommend a DHA intake of at least 200 to 300 mg per day for women during pregnancy and lactation.

Women who are pregnant, breastfeeding or trying to become pregnant can feel confident that while taking a prenatal vitamin with plant-based DHA, they are avoiding the potential worry of exposure to oceanborne toxins, such as mercury or polychlorinated biphenyl (PCB) compounds, and the fishy aftertaste or burp that may be associated with fish-based DHA.

"There is no more important time to eat a nutritious diet than during pregnancy.  Even the most conscientious mothers-to-be can benefit from the added nutritional support that prenatal vitamins provide," said Wesley Mark Todd, MD, Senior Director Medical Affairs, Upsher-Smith Laboratories, Inc. "While Nexa™ Select includes numerous vitamins and minerals to support a healthy pregnancy, the folic acid and plant-based DHA in a single capsule are especially appealing to many moms-to-be."

Nexa™ Select also provides 800 IU of vitamin D3 an essential vitamin to support mom and baby's skeletal health, 1.25 mg of folic acid and 29 mg of iron. It also contains other essential vitamins and minerals that are important for the overall health and well-being of mother and baby, including calcium and vitamins B6 and C -- as well as the gentle stool softener, docusate sodium, for added comfort.  

About DHADHA, or docosahexaenoic acid, is a key omega-3 fatty acid that is associated with a host of health benefits for mothers and babies. It helps with the development of baby's prenatal and postnatal brain and visual development. Some studies suggest that omega-3 fatty acids may promote a healthy duration of gestation and birth weight. Nexa™ Select contains plant-based life'sDHA™ which has been granted GRAS (Generally Recognized As Safe) status by the FDA for use in infant formula.  

Product InformationThe NDC number for Nexa™ Select is 0245-0244-30.  Key product features include: 30 gel capsules per bottle, a vanilla-scent, and a regimen of one capsule once daily.  

Important Safety InformationWARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six.  KEEP THIS PRODUCT OUT OF REACH OF CHILDREN.  In case of accidental overdose, call a doctor or poison control center immediately.

Please see full Prescribing Information for a complete list of warnings and precautions.

For additional information about Nexa™ Select, visit

About Upsher-SmithUpsher-Smith Laboratories, Inc. is a rapidly growing pharmaceutical company that manufactures and markets both prescription and consumer products.  Privately held since 1919, the company strives to recognize the unmet healthcare needs of its customers.  Upsher-Smith prides itself on providing safe, effective, and economical therapies to the ever-challenged healthcare environment.  To learn more about Upsher-Smith, visit Select [package insert]. Minneapolis, MN: Upsher-Smith Laboratories, Inc; 2011. PreNexa  [package insert]. Minneapolis, MN: Upsher-Smith Laboratories, Inc; 2010. CitraNatal Harmony [package insert]. San Antonio, TX: Mission Pharmacal Company; 2010. Concept DHA [package insert]. Decatur, GA: US Pharmaceutical Corp; 2009. Natelle One [package insert]. Philadelphia, PA: Azur Pharma, Inc; 2009. Neevo DHA [package insert]. Covington, LA: PamLab, LLC; 2009. OB Complete [package insert]. Sayreville, NJ: Vertical Pharmaceuticals, Inc; 2010. Prefera OB ONE [package insert]. Marietta, GA: Alaven Pharmaceutical LLC; 2010. Prenate Essential [package insert]. Atlanta, GA: Shionogi Pharma Inc; 2010.Koletzko B, et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy. J Perinat Med. 2008;36:5-14. Simonopoulos AP, Leaf A,  Salem N Jr. Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty  acids. J Am Coll Nutr. 1999;18:487-489.Martek Biosciences Corporation. Annual Report 2009. Columbia, MD. Some "healthy" fish oil supplements come with serious chemical contamination; lawsuit to force warnings. Fish oil safety Website. Accessed October 4, 2010.Environmental Defense Fund. Fish oil supplements.  Accessed October 4, 2010.Mulligan ML, Felton SK, Riek AE, et al.  Implications of vitamin D deficiency in pregnancy and lactation. Am J Obstet Gynecol 2009;201.Medline Plus.  Accessed November 1, 2010. Koletzko B, Larque E, Demmelmair H. Placental transfer of long-chain polyunsaturated fatty acids (LC-PUFA). J Perinat Med. 2007;35 (suppl 1):S5-S11.  Smuts C, et al. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. 2003;101:469.US Food and Drug Administration. Agency Response Letter GRAS No. GRN000041 [May 17, 2001]. Accessed October 4, 2010.Harris WS. Fish oil supplementation: evidence for health benefits. Cleve Clin J Med. 2004;71(3)'sDHA is a trademark of Martek Biosciences Corporation.

SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Upsher-Smith Announces New Formulation of PreNexa(R) Prenatal Vitamins
2. New Data: Cholesterol Management Analysis of Upsher-Smiths Slo-Niacin(R) Tablets in Combination with Lipitor(R)
3. Upsher-Smith Announces Milestone in Development of CNS Strategy
4. Upsher-Smith Introduces New Formulation of PreNexa® Prenatal Vitamins
5. Upsher-Smith Laboratories Announces Initiation of Phase III Clinical Trial of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
6. Upsher-Smith Laboratories Adds ITI-111 (Nasal Midazolam) to CNS Development Pipeline
7. Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem® 10 mcg
8. Upsher-Smith Laboratories Announces Initiation of Open-Label Extension Study of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
9. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
10. Dr. Dello Russo Introduces the New EYE-Q Lasik
11. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
Post Your Comments:
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):